Scholars@Duke
Journal cover image

From the editor: A run of success in treating atherosclerotic vascular disease.

Publication ,  Journal Article
Guyton, JR
Published in: J Clin Lipidol
2018
Published version (DOI) Link to item

Duke Scholars

John Richard Guyton
Author John Richard Guyton Medicine, Endocrinology, Metabolism, and Nutrition
Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Lipidol

DOI

10.1016/j.jacl.2017.12.016

ISSN

1933-2874

Publication Date

2018

Volume

12

Issue

1

Start / End Page

1 / 2

Location

United States

Related Subject Headings

  • Sodium-Glucose Transporter 2 Inhibitors
  • Proprotein Convertase 9
  • PCSK9 Inhibitors
  • Humans
  • Glucosides
  • Cardiovascular System & Hematology
  • Benzhydryl Compounds
  • Atherosclerosis
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guyton, J. R. (2018). From the editor: A run of success in treating atherosclerotic vascular disease. J Clin Lipidol, 12(1), 1–2. https://doi.org/10.1016/j.jacl.2017.12.016
Guyton, John R. “From the editor: A run of success in treating atherosclerotic vascular disease.” J Clin Lipidol 12, no. 1 (2018): 1–2. https://doi.org/10.1016/j.jacl.2017.12.016.
Guyton, John R. “From the editor: A run of success in treating atherosclerotic vascular disease.” J Clin Lipidol, vol. 12, no. 1, 2018, pp. 1–2. Pubmed, doi:10.1016/j.jacl.2017.12.016.
Journal cover image

Published In

J Clin Lipidol

DOI

10.1016/j.jacl.2017.12.016

ISSN

1933-2874

Publication Date

2018

Volume

12

Issue

1

Start / End Page

1 / 2

Location

United States

Related Subject Headings

  • Sodium-Glucose Transporter 2 Inhibitors
  • Proprotein Convertase 9
  • PCSK9 Inhibitors
  • Humans
  • Glucosides
  • Cardiovascular System & Hematology
  • Benzhydryl Compounds
  • Atherosclerosis
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal